---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-029580"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2025-03-31T23:59:59+00:00"
generated_at: "2026-05-24T01:30:42.082770+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Brainstorm Cell Therapeutics enters warrant inducement deal for ~$1.64M gross proceeds

## Summary
- Holder to exercise existing warrants for 1,381,383 shares; new warrants at 200% of exercised shares.
- New warrants have $1.19 exercise price, exercisable after stockholder approval, 5-year term.
- Gross proceeds ~$1.64M; net proceeds for working capital and general corporate purposes.
- Maxim Group acting as inducement agent with 6% cash fee and $12,500 expenses.
- Company must seek stockholder approval within 90 days; resale registration statement to be filed.

## SEC filing metadata
- accession: 0001104659-25-029580
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2025-03-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465925029580/0001104659-25-029580-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465925029580/tm2510890d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-029580
- JSON: https://secwatch.observer/filing/0001104659-25-029580.json
- Plain text: https://secwatch.observer/filing/0001104659-25-029580.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.